J&J's Tremfya Wins NMPA Approval for Crohn's Disease Treatment
CompanyDrug

J&J’s Tremfya Wins NMPA Approval for Crohn’s Disease Treatment

Sanofi's Sarclisa Wins New Japan Approval for Multiple Myeloma Combination Therapy
CompanyDrug

Sanofi’s Sarclisa Wins New Japan Approval for Multiple Myeloma Combination Therapy

YolTech Therapeutics' YOLT-203 Shows Promise in Primary Hyperoxaluria Type 1 Trial
CompanyDrug

YolTech Therapeutics’ YOLT-203 Shows Promise in Primary Hyperoxaluria Type 1 Trial

HQ Pharma and Shanghai Pharmaceuticals Expand Collaboration for Global Market Access
CompanyDeals

HQ Pharma and Shanghai Pharmaceuticals Expand Collaboration for Global Market Access

Green Valley and Vazyme Team Up on Alzheimer's Disease Initiatives
CompanyDeals

Green Valley and Vazyme Team Up on Alzheimer’s Disease Initiatives

Merck's Keytruda sBLA for LA-HNSCC Accepted by FDA for Review
CompanyDrug

Merck’s Keytruda sBLA for LA-HNSCC Accepted by FDA for Review

CARsgen Therapeutics and Zhuhai SB Xinchuang Invest in UCARsgen for Allogeneic CAR-T Therapies
CompanyDeals

CARsgen Therapeutics and Zhuhai SB Xinchuang Invest in UCARsgen for Allogeneic CAR-T Therapies

Eli Lilly Launches New Zepbound Doses with Lower Prices for Self-Pay Patients
CompanyDrug

Eli Lilly Launches New Zepbound Doses with Lower Prices for Self-Pay Patients

Suzhou Ribo Life Science's RBD2080 siRNA Drug Receives Australian Clinical Trial Approval
CompanyDrug

Suzhou Ribo Life Science’s RBD2080 siRNA Drug Receives Australian Clinical Trial Approval

MicuRx Pharmaceuticals Sues Medpace Over Breach of Contract in Phase III Study
Company

MicuRx Pharmaceuticals Sues Medpace Over Breach of Contract in Phase III Study

Eli Lilly Acquires Organovo's FXR Program for Inflammatory Bowel Disease
CompanyDeals

Eli Lilly Acquires Organovo’s FXR Program for Inflammatory Bowel Disease

CompanyMedical Device

Acotec Scientific’s Vericor Catheter Wins NMPA Approval for Peripheral Vascular Surgery